| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | Yao-Ching Hung | |
| Wei-Chun Chang | |||
| Long-Bin Jeng | |||
| Wen-Lung Ma | |||
| Bi-Hua Cheng | |||
| Wei-Chung Cheng | |||
| Mei-Due Yang | |||
| Lumin Chen | |||
| Li-Jing Ju | |||
| Yu-Jer Ou | |||
| P2860 | cites work | Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome | Q24338784 |
| HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. | Q38954515 | ||
| Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells | Q38983118 | ||
| Lovastatin inhibited the growth of gastric cancer cells | Q38988464 | ||
| Regulation of autophagy by cytosolic acetyl-coenzyme A. | Q39021728 | ||
| Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro | Q39076174 | ||
| The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma. | Q39823357 | ||
| The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial | Q42930809 | ||
| Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study. | Q53260343 | ||
| Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer. | Q53341637 | ||
| Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway. | Q54374200 | ||
| Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis | Q27496690 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer | Q28393146 | ||
| Cell biology. Metabolic control of cell death | Q28397089 | ||
| Jetset: selecting the optimal microarray probe set to represent a gene | Q34102011 | ||
| c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate | Q34139228 | ||
| Guidelines for the management of oesophageal and gastric cancer. | Q34195431 | ||
| Adjuvant therapy for gastric cancer: current and future directions | Q34326579 | ||
| Statins and risk of cancer: a systematic review and metaanalysis | Q34585294 | ||
| A novel role for Tm7sf2 gene in regulating TNFα expression | Q34917960 | ||
| CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma | Q35194416 | ||
| DriverDBv2: a database for human cancer driver gene research | Q36435002 | ||
| Effect of pravastatin on the survival of patients with advanced gastric cancer. | Q36782447 | ||
| Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis | Q36904589 | ||
| Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. | Q37061209 | ||
| Control of the innate immune response by the mevalonate pathway. | Q37114315 | ||
| Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. | Q37365527 | ||
| The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System | Q37549192 | ||
| Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells | Q37564767 | ||
| Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line | Q37606208 | ||
| DriverDB: an exome sequencing database for cancer driver gene identification. | Q37661903 | ||
| Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survival | Q37702341 | ||
| Nucleocytosolic depletion of the energy metabolite acetyl-coenzyme a stimulates autophagy and prolongs lifespan | Q37706462 | ||
| Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma | Q38527516 | ||
| Acetate as a Metabolic and Epigenetic Modifier of Cancer Therapy | Q38562373 | ||
| Does surgery have a role in managing incurable gastric cancer? | Q38563923 | ||
| HMGCR is up-regulated in gastric cancer and promotes the growth and migration of the cancer cells | Q38777617 | ||
| Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling | Q38810328 | ||
| Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization | Q38812656 | ||
| The interplay between cell signalling and the mevalonate pathway in cancer | Q38937455 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1240-1252 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression. | |
| P478 | volume | 7 |
| Q94599582 | Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress |
| Q90308002 | Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer |
| Q92059786 | Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1 |
Search more.